Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 24 10:41AM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-0.27 Insider Own22.65% Shs Outstand27.14M Perf Week30.51%
Market Cap101.14M Forward P/E- EPS next Y-0.05 Insider Trans1.57% Shs Float22.04M Perf Month4.72%
Income-8.15M PEG- EPS next Q-0.10 Inst Own34.80% Short Float3.19% Perf Quarter-2.74%
Sales19.24M P/S5.26 EPS this Y23.81% Inst Trans-0.50% Short Ratio2.25 Perf Half Y184.00%
Book/sh0.33 P/B10.72 EPS next Y76.56% ROA-65.86% Short Interest0.70M Perf Year446.32%
Cash/sh0.31 P/C11.40 EPS next 5Y-0.47% ROE-106.17% 52W Range0.37 - 5.58 Perf YTD-29.14%
Dividend Est.- P/FCF- EPS past 5Y59.45% ROI-89.49% 52W High-36.38% Beta1.49
Dividend TTM- Quick Ratio2.16 Sales past 5Y54.66% Gross Margin68.51% 52W Low856.87% ATR (14)0.27
Dividend Ex-Date- Current Ratio2.49 EPS Y/Y TTM82.09% Oper. Margin-42.78% RSI (14)59.26 Volatility9.52% 7.97%
Employees106 Debt/Eq0.07 Sales Y/Y TTM23.70% Profit Margin-42.34% Recom1.00 Target Price6.88
Option/ShortYes / Yes LT Debt/Eq0.01 EPS Q/Q76.30% Payout- Rel Volume0.21 Prev Close3.54
Sales Surprise-2.68% EPS Surprise-21.74% Sales Q/Q17.69% EarningsMar 07 AMC Avg Volume313.12K Price3.55
SMA2014.41% SMA508.03% SMA20044.43% Trades Volume14,780 Change0.28%
Date Action Analyst Rating Change Price Target Change
Dec-15-23Initiated H.C. Wainwright Buy $6.50
Nov-11-20Upgrade ROTH Capital Neutral → Buy $5 → $7
May-27-20Initiated Dougherty & Company Buy $8.50
Oct-02-17Initiated H.C. Wainwright Buy $12
Mar-28-24 04:05PM
Mar-18-24 11:00AM
Mar-08-24 10:15AM
Mar-07-24 06:00PM
08:00AM Loading…
Mar-01-24 08:00AM
Feb-29-24 04:05PM
Jan-19-24 04:05PM
Jan-17-24 08:05AM
Dec-20-23 08:50AM
Dec-12-23 07:00AM
Dec-01-23 10:00AM
Nov-20-23 04:16PM
Nov-08-23 11:47AM
04:05PM Loading…
Nov-07-23 04:05PM
Nov-06-23 08:30AM
Nov-02-23 10:08AM
Oct-31-23 04:05PM
Aug-29-23 04:05PM
Aug-28-23 12:38PM
Aug-25-23 07:00AM
Aug-24-23 07:33PM
Aug-21-23 04:05PM
Aug-09-23 05:30PM
Aug-02-23 04:05PM
Jul-05-23 10:50AM
08:30AM Loading…
Jul-03-23 08:30AM
Jun-14-23 04:05PM
May-22-23 09:55AM
May-10-23 06:05PM
May-09-23 07:05PM
May-05-23 07:45AM
May-03-23 04:05PM
Apr-10-23 08:30AM
Mar-16-23 05:30AM
Mar-15-23 08:30AM
Mar-14-23 11:11AM
Mar-13-23 09:45AM
Mar-07-23 10:12AM
Mar-06-23 04:05PM
Feb-06-23 04:05PM
Feb-01-23 04:25PM
Jan-30-23 04:05PM
Jan-17-23 04:05PM
Jan-12-23 08:30AM
Jan-10-23 04:17PM
Dec-07-22 05:00PM
Dec-05-22 08:30AM
Nov-21-22 03:04PM
Nov-10-22 05:55PM
Nov-09-22 05:25PM
Nov-03-22 04:05PM
Oct-05-22 04:30PM
Sep-07-22 08:30AM
Aug-30-22 08:30AM
Aug-03-22 06:35PM
Jul-28-22 10:03AM
Jul-27-22 04:15PM
Jul-18-22 12:00PM
Jul-07-22 04:05PM
Jun-14-22 02:45PM
Jun-09-22 04:05PM
May-25-22 10:34AM
May-11-22 06:05PM
May-04-22 04:15PM
Apr-04-22 04:15PM
Mar-09-22 05:35PM
Mar-02-22 04:15PM
Feb-17-22 04:15PM
Feb-14-22 08:30AM
Jan-18-22 07:30AM
Jan-13-22 04:30PM
Jan-10-22 08:30AM
Jan-06-22 04:05PM
Jan-05-22 04:05PM
Nov-10-21 06:25PM
Nov-03-21 04:05PM
Nov-02-21 03:02PM
Oct-15-21 09:15AM
Oct-04-21 04:30PM
Sep-28-21 04:30PM
Sep-07-21 04:30PM
Sep-02-21 04:30PM
Aug-09-21 06:15PM
Aug-02-21 04:05PM
Jul-27-21 08:30AM
Myomo, Inc. is a wearable medical robotics company, which engages in the business of developing, designing, and producing myoelectric orthotics for people with neuromuscular disorders. The firm is also involved in selling products through various other sales channels including through orthotics and prosthetics providers, veterans' administration, and to distributors in certain accounts and geographic markets. The company was founded by Stephen Kelly, John McBean, Mira Sahney, and Kailas N. Narendran on September 1, 2004 and is headquartered in Boston, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KIRK THOMAS FDirectorMar 14 '24Buy3.5050,000175,000186,499Mar 18 07:48 AM
KIRK THOMAS FDirectorNov 20 '23Buy3.1050,000155,000136,499Dec 14 07:46 PM
Morris Milton MayoDirectorSep 08 '23Buy1.0615,00015,86777,933Sep 11 05:05 PM
GUDONIS PAUL RChief Executive OfficerAug 30 '23Buy0.7448,40036,039878,245Aug 31 06:26 PM
GUDONIS PAUL RChief Executive OfficerAug 29 '23Buy0.7837,00028,797829,845Aug 30 04:22 PM
HENRY DAVID AChief Financial OfficerAug 29 '23Buy0.6041,66625,000352,193Aug 30 04:36 PM
Kovelman HarryChief Medical OfficerAug 29 '23Buy0.608,3335,000149,556Aug 30 05:00 PM
GUDONIS PAUL RChief Executive OfficerAug 28 '23Buy0.7542,50031,794792,845Aug 30 04:22 PM